Skip navigation

DAY ONE THURSDAY, OCTOBER 26, 2017

7:30

Main Conference Registration

8:30

Chairperson’s Welcome & Opening Remarks

Therese McCall
Former Vice President
AbbVie

Impact of a Changing Regulatory
Environment on Medical
Communication Practices

8:45

Revolutionize Medical Communications to Meet the Needs of
An Evolving Healthcare Landscape

Therese McCall
Former Vice President
AbbVie

9:45

Create a Compliant Strategic Communication Plan for Non-Inferiority and Bioequivalence Trials

Paul Cavanaugh, PhD
Former Senior Director
Vertex Pharmaceuticals

10:30

Networking and Refreshment Break

11:00

Panel
Drive Alignment, Improve Dialogue and Optimize Resources Across Medical and Commercial Functions to Create a Unified Brand Strategy

PANELISTS:

Dr. Shailesh Chavan
Vice President, Medical Affairs
Biotest Pharmaceuticals

Matt D'Auria
President
The Scienomics Group

Safura Babu-Khan
Director, Global Medical Affairs
Amgen

12:15

Networking Luncheon

Develop “Smart” IT Solutions for
Enhancing Medical Communications

1:30

Explore Modern and Emerging Venues for Engaging Stakeholders and Removing Communication Barriers

Michael Kirby
Vice President, Business Partnerships
Within3

Matthew R. Hawes
Associate Director
Gilead Sciences, Inc.

2:15

Enhance Medical Communication Capabilities With the Use of
New Technology and Innovations

Gregory Imber
President
Hyphen Digital

3:00

Networking and Refreshment Break

3:30

Key Strategies for Effectively Utilizing Information from Social Media to Learn More About a Patient Population

4:15

FACULTY THINK TANK
Create the Framework for Your MedComm 2.0 Plan

FACILITATOR:

Therese McCall
Former Vice President
AbbVie

5:30

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one

DAY TWO FRIDAY, OCTOBER 27, 2017

8:00

Continental Breakfast

8:30

Chairperson’s Review of Day One

Therese McCall
Former Vice President
AbbVie

8:45

Eye-Opening Breakfast Breakout

Now more than ever, medical affairs and medcomm teams are seeing a heightened emphasis on scientific exchange while also facing the pressure and focus towards transparency and compliance. This roundtable discussion delves into the interface between medical communications and compliance at the strategic level taking an objective look at how to better manage data across the entire organization. Dissect your compliance challenges, look for answers to your specific questions and share your insights with industry counterparts.

MODERATOR:

Jane Wright Mitchell
Chief Legal Officer
AcelRx

Develop Efficient Internal Strategies
to Improve Medical Communication
and Patient Outreach

9:30

Medical Content Strategy to Drive Exceptional Customer Experience

Marek Garbaczonek, MD, MBA
Group Leader, Global Medical Information
Roche/Genentech

10:15

Networking and Refreshment Break

10:45

CLOSING SESSION
Consider the Future of Medical Communication and Information as a Value-Added Function

Joseph Kohles, PhD
Chief Medical Officer
Envision Pharma Group

11:30

Close of Conference

 

Want more agenda details? Download the brochure.

DAY ONE THURSDAY, OCTOBER 26, 2017

7:30

Main Conference Registration

8:30

Chairperson’s Welcome & Opening Remarks

Therese McCall
Former Vice President
AbbVie

Impact of a Changing Regulatory
Environment on Medical
Communication Practices

8:45

Revolutionize Medical Communications to Meet the Needs of
An Evolving Healthcare Landscape

Therese McCall
Former Vice President
AbbVie

9:45

Create a Compliant Strategic Communication Plan for Non-Inferiority and Bioequivalence Trials

Paul Cavanaugh, PhD
Former Senior Director
Vertex Pharmaceuticals

10:30

Networking and Refreshment Break

11:00

Panel
Drive Alignment, Improve Dialogue and Optimize Resources Across Medical and Commercial Functions to Create a Unified Brand Strategy

PANELISTS:

Dr. Shailesh Chavan
Vice President, Medical Affairs
Biotest Pharmaceuticals

Matt D'Auria
President
The Scienomics Group

Safura Babu-Khan
Director, Global Medical Affairs
Amgen

12:15

Networking Luncheon

Develop “Smart” IT Solutions for
Enhancing Medical Communications

1:30

Explore Modern and Emerging Venues for Engaging Stakeholders and Removing Communication Barriers

Michael Kirby
Vice President, Business Partnerships
Within3

Matthew R. Hawes
Associate Director
Gilead Sciences, Inc.

2:15

Enhance Medical Communication Capabilities With the Use of
New Technology and Innovations

Gregory Imber
President
Hyphen Digital

3:00

Networking and Refreshment Break

3:30

Key Strategies for Effectively Utilizing Information from Social Media to Learn More About a Patient Population

4:15

FACULTY THINK TANK
Create the Framework for Your MedComm 2.0 Plan

FACILITATOR:

Therese McCall
Former Vice President
AbbVie

5:30

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one

DAY TWO FRIDAY, OCTOBER 27, 2017

8:00

Continental Breakfast

8:30

Chairperson’s Review of Day One

Therese McCall
Former Vice President
AbbVie

8:45

Eye-Opening Breakfast Breakout

Now more than ever, medical affairs and medcomm teams are seeing a heightened emphasis on scientific exchange while also facing the pressure and focus towards transparency and compliance. This roundtable discussion delves into the interface between medical communications and compliance at the strategic level taking an objective look at how to better manage data across the entire organization. Dissect your compliance challenges, look for answers to your specific questions and share your insights with industry counterparts.

MODERATOR:

Jane Wright Mitchell
Chief Legal Officer
AcelRx

Develop Efficient Internal Strategies
to Improve Medical Communication
and Patient Outreach

9:30

Medical Content Strategy to Drive Exceptional Customer Experience

Marek Garbaczonek, MD, MBA
Group Leader, Global Medical Information
Roche/Genentech

10:15

Networking and Refreshment Break

10:45

CLOSING SESSION
Consider the Future of Medical Communication and Information as a Value-Added Function

Joseph Kohles, PhD
Chief Medical Officer
Envision Pharma Group

11:30

Close of Conference